Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Assist Reprod Genet ; 40(9): 2157-2173, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-37450097

RESUMEN

BACKGROUND: Expanded carrier screening (ECS) has become a common practice for identifying carriers of monogenic diseases. However, existing large gene panels are not well-tailored to Chinese populations. In this study, ECS testing for pathogenic variants of both single-nucleotide variants (SNVs) and copy number variants (CNVs) in 330 genes implicated in 342 autosomal recessive (AR) or X-linked diseases was carried out. We assessed the differences in allele frequencies specific to the Chinese population who have used assisted reproductive technology (ART) and the important genes to screen for in this population. METHODOLOGY: A total of 300 heterosexual couples were screened by our ECS panel using next-generation sequencing. A customed bioinformatic algorithm was used to analyze SNVs and CNVs. Guidelines from the American College of Medical Genetics and Genomics and the Association for Molecular Pathology were adapted for variant interpretation. Pathogenic or likely pathogenic (P/LP) SNVs located in high homology regions/deletions and duplications of one or more exons in length were independently verified with other methods. RESULTS: 64.83% of the patients were identified to be carriers of at least one of 342 hereditary conditions. We identified 622 P/LP variants, 4.18% of which were flagged as CNVs. The rate of at-risk couples was 3%. A total of 149 AR diseases accounted for 64.05% of the cumulative carrier rate, and 48 diseases had a carrier rate above 1/200 in the test. CONCLUSION: An expanded screening of inherited diseases by incorporating different variant types, especially CNVs, has the potential to reduce the occurrence of severe monogenic diseases in the offspring of patients using ART in China.


Asunto(s)
Pueblos del Este de Asia , Tamización de Portadores Genéticos , Enfermedades Genéticas Congénitas , Técnicas Reproductivas Asistidas , Humanos , China/epidemiología , Pueblos del Este de Asia/genética , Exones , Frecuencia de los Genes/genética , Pruebas Genéticas , Enfermedades Genéticas Congénitas/diagnóstico , Enfermedades Genéticas Congénitas/genética , Enfermedades Genéticas Congénitas/prevención & control
2.
Sci Rep ; 10(1): 4296, 2020 03 09.
Artículo en Inglés | MEDLINE | ID: mdl-32152338

RESUMEN

The antibiotic 2,4-diacetylphoroglucinol (2,4-DAPG), produced by the Gram-negative rod-shaped bacterium Pseudomonas fluorescens 2P24, is active against various soil-borne bacterial and fungal pathogens that cause plant diseases. Biosynthesis of 2,4-DAPG is controlled by regulating expression of the phlACBD operon at the post-transcriptional level. The phlG gene is located between the phlF and phlH genes, upstream of the phlACBD biosynthetic operon. Herein, we cloned the phlG gene, generated a phlG deletion mutant, and investigated its regulatory role in 2,4-DAPG biosynthesis. The results showed that deletion of phlG had no effect on the biosynthesis of 2,4-DAPG, but it affected conversion of 2,4-DAPG to its precursor monoacetylphloroglucinol (MAPG). The global regulatory factor encoded by gacS positively regulated expression of phlG, while rsmE negatively regulated its expression. Deleting phlG did not alter the ability of the bacterium to colonise plants or promote plant growth. These results suggest that phlG collaborates with other factors to regulate production of the antibiotic 2,4-DAPG in P. fluorescens 2P24.


Asunto(s)
Antibacterianos/farmacología , Proteínas Bacterianas/metabolismo , Floroglucinol/análogos & derivados , Enfermedades de las Plantas/inmunología , Pseudomonas fluorescens/crecimiento & desarrollo , Triticum/crecimiento & desarrollo , Proteínas Bacterianas/genética , Floroglucinol/metabolismo , Enfermedades de las Plantas/microbiología , Pseudomonas fluorescens/metabolismo , Triticum/efectos de los fármacos , Triticum/microbiología
3.
Molecules ; 25(1)2019 Dec 24.
Artículo en Inglés | MEDLINE | ID: mdl-31878172

RESUMEN

The coumarin compound of osthole was extracted from Cnidium monnieri and identified by LC-MS and 1H- and 13C-NMR. Osthole was tested for anti-virus activity against tobacco mosaic virus (TMV) using the half-leaf method. The results showed that stronger antiviral activity on TMV infection appeared in Nicotiana glutinosa than that of eugenol and ningnanmycin, with inhibitory, protective, and curative effects of 72.57%, 70.26%, and 61.97%, respectively. Through observation of the TMV particles, we found that osthole could directly affect the viral particles. Correspondingly, the level of coat protein detected by Western blot was significantly reduced when the concentrations of osthole increased in tested plants compared to that of the control. These results suggest that osthole has anti-TMV activity and may be used as a biological reagent to control the plant virus in the half-leaf method.


Asunto(s)
Cnidium/química , Cumarinas/farmacología , Nicotiana/virología , Enfermedades de las Plantas/terapia , Enfermedades de las Plantas/virología , Virus del Mosaico del Tabaco/efectos de los fármacos , Virus del Mosaico del Tabaco/fisiología , Antivirales/farmacología , Proteínas de la Cápside/metabolismo , Cumarinas/química , Cinética , Virus del Mosaico del Tabaco/ultraestructura , Virión/efectos de los fármacos , Virión/ultraestructura
4.
Molecules ; 24(11)2019 Jun 06.
Artículo en Inglés | MEDLINE | ID: mdl-31174300

RESUMEN

In this study, two phenol compounds, magnolol and honokiol, were extracted from Magnolia officinalis and identified by LC-MS, 1H- and 13C-NMR. The magnolol and honokiol were shown to be effective against seven pathogenic fungi, including Alternaria alternata (Fr.) Keissl, Penicillium expansum (Link) Thom, Alternaria dauci f.sp. solani, Fusarium moniliforme J. Sheld, Fusarium oxysporum Schltdl., Valsa mali Miyabe & G. Yamada, and Rhizoctonia solani J.G. Kühn, with growth inhibition of more than 57%. We also investigated the mechanisms underlying the potential antifungal activity of magnolol and honokiol. The results showed that they inhibited the growth of A. alternata in a dose-dependent manner. Moreover, magnolol and honokiol treatment resulted in distorted mycelia and increased the cell membrane permeability of A. alternata, as determined by conductivity measurements. These results suggest that magnolol and honokiol are potential antifungal agents for application against plant fungal diseases.


Asunto(s)
Compuestos de Bifenilo/química , Compuestos de Bifenilo/farmacología , Lignanos/química , Lignanos/farmacología , Magnolia/efectos de los fármacos , Enfermedades de las Plantas/microbiología , Alternaria/efectos de los fármacos , Alternaria/patogenicidad , Antifúngicos/química , Antifúngicos/farmacología , Magnolia/química , Nicotiana/efectos de los fármacos , Nicotiana/microbiología
5.
Acta Biochim Biophys Sin (Shanghai) ; 38(1): 22-8, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16395523

RESUMEN

RNA interference (RNAi) silences gene expression by guiding mRNA degradation in a sequence-specific fashion. Small interfering RNA (siRNA), an intermediate of the RNAi pathway, has been shown to be very effective in inhibiting virus infection in mammalian cells and cultured plant cells. Here, we report that Agrobacterium tumefaciens-mediated transient expression of short hairpin RNA (shRNA) could inhibit tobacco mosaic virus (TMV) RNA accumulation by targeting the gene encoding the replication-associated 126 kDa protein in intact plant tissue. Our results indicate that transiently expressed shRNA efficiently interfered with TMV infection. The interference observed is sequence-specific, and time- and site-dependent. Transiently expressed shRNA corresponding to the TMV 126 kDa protein gene did not inhibit cucumber mosaic virus (CMV), an unrelated tobamovirus. In order to interfere with TMV accumulation in tobacco leaves, it is essential for the shRNA constructs to be infiltrated into the same leaves as TMV inoculation. Our results support the view that RNAi opens the door for novel therapeutic procedures against virus diseases. We propose that a combination of the RNAi technique and Agrobacterium-mediated transient expression could be employed as a potent antiviral treatment in plants.nt antiviral treatment in plants.


Asunto(s)
Nicotiana/genética , Nicotiana/virología , Enfermedades de las Plantas/virología , ARN Interferente Pequeño/genética , Virus del Mosaico del Tabaco/fisiología , Proteínas Virales/genética , Agrobacterium tumefaciens/genética , Silenciador del Gen , Marcación de Gen/métodos , Vectores Genéticos , Enfermedades de las Plantas/genética , Virus del Mosaico del Tabaco/patogenicidad , Transfección/métodos , Proteínas Virales/metabolismo
6.
Acta Biochim Biophys Sin (Shanghai) ; 37(4): 248-53, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15806291

RESUMEN

Plant viruses encode suppressors of post-transcriptional gene silencing (PTGS), an adaptive defense response that limits virus replication and its spread in plants. The helper component proteinase (HC-Pro) of the potato virus A (PVA, genus Potyvirus) suppresses PTGS of silenced transgenes. Here, the effect of HC-Pro on siRNA-directed interference in the tobacco mosaic virus (TMV) was examined by using a transient Agrobacterium tumefaciens-based delivery system in intact tissues. It was shown that the interference effect was completely blocked by co-infiltration with HC-Pro plus siRNA constructs in both systemic and hypersensitive hosts. In the system host, all plants agro-infiltrated with HC-Pro plus siRNA constructs displayed the same symptoms as the negative control. Meanwhile, TMV RNA accumulation was found to be abundant in the upper leaves using reverse transcriptase-PCR (RT-PCR) and Northern blot assays. On the contrary, plants agro-infiltrated with the siRNA construct alone were free of symptoms. Therefore, our study suggests that the transient expression of HC-Pro inhibited the siRNA-directed host defenses against TMV infection.


Asunto(s)
Cisteína Endopeptidasas/genética , Cisteína Endopeptidasas/metabolismo , Mejoramiento Genético/métodos , Nicotiana/metabolismo , Nicotiana/virología , Enfermedades de las Plantas/virología , Virus del Mosaico del Tabaco/fisiología , Proteínas Virales/genética , Proteínas Virales/metabolismo , Silenciador del Gen , Hojas de la Planta/metabolismo , Hojas de la Planta/virología , Plantas Modificadas Genéticamente/metabolismo , Plantas Modificadas Genéticamente/virología , ARN Interferente Pequeño/genética , Proteínas Recombinantes/metabolismo , Nicotiana/genética , Transfección/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...